---
figid: PMC5495464__nihms861216f3
figlink: /pmc/articles/PMC5495464/figure/F3/
number: F3
caption: Interactions of IGF and ERβ signaling pathways in malignancy. TNBC proliferation
  is regulated closely by a complex network of growth factor signaling pathways. It
  is well known that obesity and diabetes can increase insulin and insulin-like growth
  factor signaling, which in turn may stimulate specific receptors to drive the activation
  of downstream signaling pathways in TNBC. IGF-1 and IGF-2 bind receptors activating
  PI3K and Akt signaling and downstream mTOR activation that promotes protein synthesis,
  cell proliferation, and inhibition of apoptosis. In addition, EGFR is frequently
  overexpressed in TNBC and is stimulated by binding with epidermal growth factor
  (EGF). Cross-communication of EGFR signaling with ERβ may induce downstream signaling
  that contributes to tumor cell survival. ERβ is activated by estrogen (E2) and by
  synthetic estrogen receptor-selective ligands such as diarylpropionitrile (DPN)
  and can reportedly be modulated in part by breast cancer therapies such as toremifene,
  tamoxifen, and raloxifen. IGF-2 signaling may also promote acute phosphorylation
  of ERβ and late induction of ERβ transcription. Metformin, a common therapeutic
  used to manage diabetes mellitus type 2, has been demonstrated to be effective in
  partial suppression of TNBC by activating AMPK (which in turn inhibits mTOR downstream
  signaling) and/or by suppressing systemic insulin-like growth factor levels in vivo.
  Arrows represent a pathway of activation and solid lines represent inhibition. See
  text for details.
pmcid: PMC5495464
papertitle: Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential
  Therapeutic Targets for Triple-Negative Breast Cancer.
reftext: Nalo Hamilton, et al. Crit Rev Oncog. ;20(5-6):373-390.
pmc_ranked_result_index: '15188'
pathway_score: 0.966402
filename: nihms861216f3.jpg
figtitle: Interactions of IGF and ERB signaling pathways in malignancy
year: ''
organisms: Homo sapiens
ndex: ed0e11d5-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5495464__nihms861216f3.html
  '@type': Dataset
  description: Interactions of IGF and ERβ signaling pathways in malignancy. TNBC
    proliferation is regulated closely by a complex network of growth factor signaling
    pathways. It is well known that obesity and diabetes can increase insulin and
    insulin-like growth factor signaling, which in turn may stimulate specific receptors
    to drive the activation of downstream signaling pathways in TNBC. IGF-1 and IGF-2
    bind receptors activating PI3K and Akt signaling and downstream mTOR activation
    that promotes protein synthesis, cell proliferation, and inhibition of apoptosis.
    In addition, EGFR is frequently overexpressed in TNBC and is stimulated by binding
    with epidermal growth factor (EGF). Cross-communication of EGFR signaling with
    ERβ may induce downstream signaling that contributes to tumor cell survival. ERβ
    is activated by estrogen (E2) and by synthetic estrogen receptor-selective ligands
    such as diarylpropionitrile (DPN) and can reportedly be modulated in part by breast
    cancer therapies such as toremifene, tamoxifen, and raloxifen. IGF-2 signaling
    may also promote acute phosphorylation of ERβ and late induction of ERβ transcription.
    Metformin, a common therapeutic used to manage diabetes mellitus type 2, has been
    demonstrated to be effective in partial suppression of TNBC by activating AMPK
    (which in turn inhibits mTOR downstream signaling) and/or by suppressing systemic
    insulin-like growth factor levels in vivo. Arrows represent a pathway of activation
    and solid lines represent inhibition. See text for details.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT1
  - PRKAG3
  - PRKAG2
  - PRKAA2
  - IGF2
  - STAT3
  - AKT3
  - MAPK14
  - MAPK1
  - MAPK3
  - PRKAA1
  - MAPK8
  - MAPK11
  - IGFBP1
  - IGF2R
  - PRKAB2
  - PIK3CB
  - PIK3CD
  - PRKAB1
  - PIK3R3
  - IGFBP3
  - IGFBP4
  - PIK3CG
  - IGFBP2
  - IRS1
  - ESR2
  - MAPK9
  - IGFBP7
  - MAPK10
  - MAPK13
  - IGF1
  - IGF1R
  - EGF
  - EGFR
  - MAPK12
  - PRKAG1
  - PIK3R5
  - IGFBP6
  - PIK3CA
  - PIK3R4
  - IGFBP5
  - MTOR
  - PIK3R6
  - metformin
  - Tamoxifen
  - Toremifene
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: IGF-2
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: stat3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP1
  entrez: '3484'
- word: IGF-2R
  symbol: IGF2R
  source: hgnc_symbol
  hgnc_symbol: IGF2R
  entrez: '3482'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP3
  entrez: '3486'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP4
  entrez: '3487'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP2
  entrez: '3485'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: ERB
  symbol: ER-beta
  source: hgnc_alias_symbol
  hgnc_symbol: ESR2
  entrez: '2100'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP7
  entrez: '3490'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AMPK)
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP6
  entrez: '3489'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP5
  entrez: '3488'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: metformin
  source: MESH
  identifier: D008687
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: Toremifene
  source: MESH
  identifier: D017312
diseases: []
figid_alias: PMC5495464__F3
redirect_from: /figures/PMC5495464__F3
figtype: Figure
---
